TY - JOUR
T1 - May the Force Be With You
T2 - The Light and Dark Sides of the Microbiota–Gut–Brain Axis in Neuropsychiatry
AU - Sherwin, Eoin
AU - Sandhu, Kiran V.
AU - Dinan, Timothy G.
AU - Cryan, John F.
N1 - Publisher Copyright:
© 2016, The Author(s).
PY - 2016/11/1
Y1 - 2016/11/1
N2 - The role of the gut microbiota in health and disease is becoming increasingly recognized. The microbiota–gut–brain axis is a bi-directional pathway between the brain and the gastrointestinal system. The bacterial commensals in our gut can signal to the brain through a variety of mechanisms, which are slowly being resolved. These include the vagus nerve, immune mediators and microbial metabolites, which influence central processes such as neurotransmission and behaviour. Dysregulation in the composition of the gut microbiota has been identified in several neuropsychiatric disorders, such as autism, schizophrenia and depression. Moreover, preclinical studies suggest that they may be the driving force behind the behavioural abnormalities observed in these conditions. Understanding how bacterial commensals are involved in regulating brain function may lead to novel strategies for development of microbiota-based therapies for these neuropsychiatric disorders.
AB - The role of the gut microbiota in health and disease is becoming increasingly recognized. The microbiota–gut–brain axis is a bi-directional pathway between the brain and the gastrointestinal system. The bacterial commensals in our gut can signal to the brain through a variety of mechanisms, which are slowly being resolved. These include the vagus nerve, immune mediators and microbial metabolites, which influence central processes such as neurotransmission and behaviour. Dysregulation in the composition of the gut microbiota has been identified in several neuropsychiatric disorders, such as autism, schizophrenia and depression. Moreover, preclinical studies suggest that they may be the driving force behind the behavioural abnormalities observed in these conditions. Understanding how bacterial commensals are involved in regulating brain function may lead to novel strategies for development of microbiota-based therapies for these neuropsychiatric disorders.
UR - https://www.scopus.com/pages/publications/84978863659
U2 - 10.1007/s40263-016-0370-3
DO - 10.1007/s40263-016-0370-3
M3 - Article
C2 - 27417321
AN - SCOPUS:84978863659
SN - 1172-7047
VL - 30
SP - 1019
EP - 1041
JO - CNS Drugs
JF - CNS Drugs
IS - 11
ER -